Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 113,185 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 113,185 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The shares were purchased at an average cost of $0.50 per share, for a total transaction of $56,592.50. Following the acquisition, the chief executive officer owned 7,244,979 shares in the company, valued at $3,622,489.50. This represents a 1.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The stock was purchased at an average price of $0.52 per share, with a total value of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The shares were purchased at an average price of $0.52 per share, for a total transaction of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The stock was acquired at an average price of $0.54 per share, with a total value of $72,334.62.
• On Friday, December 19th, Grigorios Siokas bought 88,314 shares of Cosmos Health stock. The shares were bought at an average cost of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas bought 168,472 shares of Cosmos Health stock. The stock was bought at an average price of $0.42 per share, for a total transaction of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.64 per share, with a total value of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were acquired at an average price of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas purchased 51,315 shares of Cosmos Health stock. The stock was bought at an average price of $0.62 per share, with a total value of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas bought 61,614 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Stock Up 1.9%

Shares of NASDAQ:COSM traded up $0.01 during trading on Tuesday, reaching $0.51. 610,842 shares of the stock were exchanged, compared to its average volume of 646,326. Cosmos Health Inc. has a 1-year low of $0.28 and a 1-year high of $1.32. The stock has a fifty day moving average of $0.57 and a two-hundred day moving average of $0.73. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.99 and a quick ratio of 0.84. The firm has a market cap of $19.20 million, a price-to-earnings ratio of -0.68 and a beta of 5.37.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to the consensus estimate of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Research analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC raised its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 12.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on COSM shares. Wall Street Zen upgraded shares of Cosmos Health to a “hold” rating in a research report on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.